Global, regional, and national levels of maternal mortality, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Authors: Ye Wei, Hong Luo, Xiaoyu Liu, Gongpeng Sun, Jianhong Liu, Xiao Wei, Canhui Cao, Ying Zheng Published: 2025 ABSTRACT AbstractBackgroundDespite global declines in the maternal mortality ratio (MMR), significant disparities persist across regions and socioeconomic strata. This study aims to examine spatiotemporal trends in MMR from 1990 to 2021, with a specific breakdown by age, socio-demographic index (SDI) and cause of death, to better clarify the underlying determinants of these patterns.MethodsUtilizing data from the Global Burden of Disease (GBD) Study 2021, we examined MMR trends attributable to ten distinct causes across 204 countries and territories from 1990 to 2021. Analyses were stratified by the SDI, and temporal patterns in age-specific and regional MMR distribution were evaluated.ResultsThe global MMR declined from 260.02 per 100,000 live births in 1990 to 147.77 per 100,000 live births in 2021. High SDI regions plateaued at 17.76 deaths per 100,000, whereas low-SDI regions continued to experience a significantly higher burdened (286.49 deaths per 100,000). Age-specific mortality exhibited a U-shaped curve, with peaks among individuals aged 10–19 years and 35–49 age groups. Maternal hemorrhage and hypertensive disorders emerged as the predominant global causes of maternal deaths, with regional variations: abortion-related complications prevailed in high-SDI regions, while sub-Saharan Africa bore a disproportionate burden from HIV/AIDS and other indirect causes disproportionately affected sub-Saharan Africa.ConclusionsThere is a persistent global disparity in MMR despite overall declines. Achieving the Sustainable Development Goals (SDGs) requires addressing inequities through strengthened health data systems, expanded maternal healthcare coverage, improved access to contraception and safe abortion, and enhanced health system monitoring. Evaluating SDI is crucial for tailored strategies to optimize health systems and improve maternal health outcomes worldwide.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12884-025-08456-5.Keywords: Maternal mortality ratio, Global burden of disease, Socio-demographic index Introduction According to the International Classification of Diseases, 10th Revision (ICD-10), a maternal death is defined as the death of a woman while pregnant or within 42 days of the termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management, excluding accidental or incidental causes [1]. The Maternal Mortality Ratio (MMR), defined as the number of maternal deaths per 100,000 live births, quantifies the risk of death associated with pregnancy and childbirth, and plays a crucial role in the formulation of public health policies and intervention measures [2, 3]. As a key indicator of maternal health and overall health system performance, MMR is also central to Sustainable Development Goals (SDGs) 3.1, which aims to reduce the global MMR to fewer than 70 deaths per 100,000 live births by 2030 [4]. Despite global declines in MMR over recent decades, maternal mortality remains a major public health challenge in many low- and middle-income countries (LMICs). The most recent estimates from the United Nations Maternal Mortality Estimation Inter-Agency Group (MMEIG, 2025) indicate that in 2023, more than 700 women died every day from preventable pregnancy-related causes [5]. Between 2000 and 2023, approximately 95% of maternal deaths occurred in low- and lower-middle-income countries [5]. Globally, the leading causes of maternal death are haemorrhage, hypertensive disorders of pregnancy, and indirect obstetric causes, with additional contributions from abortion, pregnancy-related infections, and embolism. Marked regional variations exist: haemorrhage is more prevalent in sub-Saharan Africa and parts of Asia, whereas hypertensive disorders are relatively more prominent in Latin America and the Caribbean [6]. Although MMR has generally declined worldwide, progress remains insufficient to meet SDG 3.1 targets, and pronounced disparities persist across regions as well as between urban and rural areas. These disparities stem from unequal distribution of healthcare resources, differences in economic development, limited maternal health education, and variable access to essential obstetric services [7–10]. For example, MMR in developing countries is much higher than in developed nations, and MMR in rural areas is generally higher than in urban areas [8, 9]. These disparities are likely related to uneven distribution of medical resources, differences in economic development [10]. Moreover, socio-economic factors (such as poverty and low education levels) and the accessibility of healthcare systems (e.g., lack of obstetric emergency services) are also considered important factors affecting MMR [9, 10]. Previous research has primarily focused on global or national-level estimates, with limited attention to long-term, age-specific, and cause-specific patterns across regions. To address this gap, the present study employs data from the Global Burden of Disease Study 2021 (GBD 2021) to examine spatiotemporal trends in MMR from 1990 to 2021, stratified by cause of death, age group, and socio-demographic index (SDI) [11]. The aim is to elucidate dynamic changes in MMR across regions, identify key determinants, and provide evidence to guide efforts in reducing maternal mortality and strengthening public health policy. Methods Data sources We conducted a retrospective study to examine the trends in MMR and its association with the SDI from 1990 to 2021. Data was obtained from the GBD 2021, which provides comprehensive estimates of MMR at global, regional, and national levels [11]. The study population included women of reproductive age (10–54 years) from all countries and territories worldwide. We stratified the population based on SDI levels and geographic regions to analyze the impact of socioeconomic development and regional disparities on MMR. SDI analysis SDI is a composite measure that quantifies the socio-economic development of a population by integrating key indicators such as income, education, and fertility rates [12]. This study examines how developmental differences affect health outcomes by analyzing the correlation between SDI and MMR. It is calculated based on three key indicators: per capita income, mean years of education for individuals aged 15 years and older, and total fertility rate for women under the age of 25. Each of these indicators is standardized on a scale from 0 to 1, where 0 represents the lowest development 1 represents the highest development [12]. In this study, SDI was used to stratify countries and regions into five categories: low, low-middle, middle, high-middle, and high SDI levels. This stratification allows for the analysis of MMR trends and patterns across different levels of socio-demographic development. MMR estimation The GBD 2021 estimated the MMR using a comprehensive approach [13–15]. Data were collected from multiple sources, including national statistical offices, population censuses, vital registration systems, hospital records, and surveys such as the Demographic and Health Surveys and Multiple Indicator Cluster Surveys. In this study, maternal death was defined according to the GBD framework. In GBD, maternal deaths include all deaths due to obstetric complications (direct maternal deaths) or concurrent conditions aggravated by pregnancy (indirect maternal deaths) occurring up to one year after the end of pregnancy, irrespective of pregnancy outcome, while excluding accidental and incidental causes. This differs from the WHO/ICD-11 definition, which restricts maternal deaths to deaths occurring within 42 days postpartum. We explicitly note this difference to clarify the scope of estimates reported here [2]. MMR was calculated as the number of maternal deaths per 100,000 live births. To address data gaps, GBD 2021 employed statistical modeling techniques, such as hierarchical regression models, time-series analyses, and spatial smoothing, incorporating variables like healthcare quality, income levels, and education [12, 15]. Because these estimates are generated through statistical models and incorporate uncertainty distributions, the resulting number of maternal deaths at global, regional, and national levels may not always be integers but decimal values [16]. This reflects the nature of modeled estimates, which aim to provide the most accurate representation of population-level mortality patterns rather than literal counts from complete vital registration [17]. Adjustments were made for indirect causes of maternal deaths and regional risk factors, including healthcare access and nutritional status. Uncertainty intervals (UI) were generated to account for potential errors in data and modeling. The final estimates were reported at global, regional, and national levels, providing a standardized assessment of MMR trends over time. Age-specific estimation To investigate age-related patterns, the GBD 2021 database provided maternal mortality estimates stratified by five-year age groups (10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, and 45–49 years) [14]. Cause-specific maternal deaths were assigned to each age group using GBD’s cause-of-death ensemble modeling (CODEm) framework, which incorporates multiple covariates such as fertility rates, healthcare access, and maternal comorbidities [18]. These estimates accounted for both direct obstetric causes (e.g., hemorrhage, hypertensive disorders) and indirect causes (e.g., HIV/AIDS, cardiovascular disease), with UI generated through 1,000 model draws. The age-specific MMR was calculated as the number of maternal deaths per 100,000 live births in each age group, ensuring comparability across countries and time periods. This approach enabled a standardized evaluation of how the causes and levels of maternal mortality vary by maternal age [14, 18]. Outcome measures The primary outcome was the MMR, defined as the number of maternal deaths per 100,000 live births. For the cause-specific analyses presented in this paper, Maternal deaths were defined as deaths occurring during pregnancy or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management. Secondary outcomes included the leading causes of maternal deaths, such as maternal hemorrhage, indirect maternal deaths, maternal abortion and miscarriage, HIV/AIDS-related indirect maternal deaths, maternal hypertensive disorders, maternal sepsis and other maternal infections, other direct maternal disorders, and ectopic pregnancy. It is important to note that two definitions of maternal death were used in this study for different analytical purposes. The GBD 2021 definition—which includes deaths up to one year after the end of pregnancy—was applied for estimating the overall MMR and assessing temporal and regional trends. However, for cause-specific analyses, we adopted the WHO/ICD-11 definition, which restricts maternal deaths to those occurring within 42 days after termination of pregnancy. This approach ensures comparability with previous cause-of-death classifications and aligns with how the GBD study reports specific causes of maternal death. Nevertheless, this definitional difference means that deaths occurring between 43 days and one year postpartum—classified as “late maternal deaths” under ICD-11—were included in the overall MMR estimation but excluded from the cause-specific breakdowns. Consequently, the cause-specific proportions may slightly underestimate the contribution of conditions with higher risks in the late postpartum period. Statistical analysis We employed several statistical methods to analyze the data. First, we assessed trends in MMR between 1990 and 2021 by calculating the estimated annual percentage change (EAPC), a measure used to quantify the average annual rate of change for a given outcome over a defined time period, usually derived from a regression model fitted to the natural logarithm of the rate to identify significant changes in mortality [19]. Second, we used linear regression models to examine the relationship between SDI and MMR, stratified by SDI levels and geographic regions. Third, we analyzed the distribution of leading causes of maternal deaths across different SDI levels and their contribution to MMR. Data analysis was performed using R software (version 4.2.0). Ethical considerations This study utilized publicly available, anonymized data and did not involve direct human subjects. Therefore, ethical approval was not required. However, the study adhered to the principles of the Declaration of Helsinki [20], ensuring transparency and scientific integrity in data use and analysis. Results Trends in global maternal deaths and MMR from 1990 to 2021 From 1990 to 2021, the number of global maternal deaths gradually declined. In 1990, the number of maternal deaths was 342,498 (95% UI 310,096–376,903), while in 2021, it decreased to 191,152 (95% UI 161,460–227,097) (Fig. 1A and Table 1). The global MMR also showed a steady decline over the past three decades, decreasing from 260.02 (95% UI 236.36–285.66) in 1990 to 147.77 (95% UI 125.28–174.47) in 2021 (Fig. 1B and Table 1), indicating significant improvements in maternal health. Global Trends in Maternal Mortality Ratio (MMR) and Maternal Deaths (1990–2021): Annual Changes, Distribution by Cause and Age in 2021, and MMR Based on SDI. A Global trends in maternal deaths (in thousands) from 1990 to 2021. The y-axis shows the number of deaths (range: 160–380 thousand), and the x-axis denotes the years. B Global trends in MMR (per 100,000 live births) from 1990 to 2021. The y-axis represents MMR values (range: 120–300), and the x-axis denotes the years. C MMR (per 100,000 live births) stratified by age groups. The x-axis lists age categories (10–14 to 50–54 years), and the y-axis represents MMR values (range: 0–4,000). D Global proportion of total maternal deaths in 2021, distributed by underlying cause and age group. The stacked area chart shows the proportion of maternal deaths globally in 2021 due to various causes, as a function of female age groups. E Global MMR from 1990 to 2021, based on SDI. MMR from 1990 to 2021, calculated based on five SDI categories and global data. Each line and its corresponding color represent one category Table 1Global and regional number of maternal deaths, maternal mortality ratio (MMR; number of deaths per 100 000 livebirths), and estimated annual percentage change of MMR, 1990–2021LocationNumber of maternal deathsMaternal mortality ratio (per 100 000 livebirths)Estimated annual percentage change1990202119902021Global342498 (310096, 376903)191152 (161460, 227097)260.02 (236.36, 285.66)147.77 (125.28, 174.47)−2.18 (−2.36, −2.00)SDI levels High SDI2129 (1816, 2488)1815 (1553, 2147)17.14 (14.54, 20.13)17.76 (15.23, 21.15)0.78 (0.53, 1.03) High-middle SDI11251 (9107, 13448)2565 (2159, 3115)62.02 (50.79, 74.10)22.08 (18.51, 26.79)−3.90 (−4.20, −3.61) Middle SDI64676 (57104, 74203)23137 (20233, 26826)156.49 (137.96, 178.54)72.52 (63.05, 83.86)−3.00 (−3.25, −2.74) Low-middle SDI150700 (136157, 165225)59693 (50310, 71556)398.88 (362.38, 436.68)151.93 (129.11, 180.73)−3.40 (−3.56, −3.24) Low SDI113557 (97940, 129071)103779 (85399, 126968)516.90 (449.05, 587.52)286.49 (233.73, 349.90)−1.94 (−2.04, −1.85)GBD regional levels Central Sub-Saharan Africa11256 (7976, 14579)15488 (10719, 21354)434.40 (309.55, 563.85)347.15 (244.19, 473.50)−0.25 (−0.56, 0.05) Eastern Sub-Saharan Africa44466 (37847, 51223)36794 (29796, 45671)491.98 (419.09, 566.22)267.01 (216.98, 329.01)−2.11 (−2.21, −2.01) Western Sub-Saharan Africa38,705 (30,343, 46,961)53572 (41988, 68524)428.96 (338.78, 525.16)300.20 (235.88, 388.49)−1.21 (−1.30, −1.12) Southern Sub-Saharan Africa3419 (2665, 4399)3047 (2340, 3961)209.76 (162.71, 267.97)186.20 (144.54, 239.85)0.80 (−0.27, 1.89) North Africa and Middle East20459 (16447, 24383)11411 (8295, 15075)183.89 (149.22, 218.80)94.05 (68.46, 126.02)−2.43 (−2.56, −2.30) South Asia157627 (141050, 173841)46152 (37716, 56479)483.69 (434.83, 532.80)144.14 (118.23, 179.39)−4.31 (−4.57, −4.04) Southeast Asia31436 (27056, 35968)11678 (9468, 14601)255.88 (221.06, 292.78)104.56 (85.57, 130.15)−3.17 (−3.35, −2.99) East Asia16032 (10880, 21817)1699 (1215, 2327)67.53 (46.45, 92.33)15.17 (10.80, 20.72)−5.43 (−5.93, −4.93) Central Asia987 (889, 1091)469 (394, 562)50.10 (45.20, 55.50)22.64 (18.59, 27.01)−2.99 (−3.18, −2.80) Oceania520 (272, 770)879 (591, 1234)232.52 (126.17, 349.62)203.70 (138.36, 278.63)−0.35 (−0.57, −0.13) Australasia22 (19, 26)12 (10, 15)7.14 (6.03, 8.26)3.45 (2.79, 4.13)−2.54 (−3.13, −1.94) Caribbean1618 (1277, 2036)1878 (1268, 2632)178.58 (140.17, 230.68)235.13 (157.77, 326.04)1.43 (1.13, 1.73) Central Latin America5002 (4595, 5422)2698 (2261, 3222)99.72 (92.48, 108.36)69.61 (57.25, 82.97)−1.20 (−1.50, −0.89) Andean Latin America2553 (2185, 2963)1370 (1024, 1792)215.47 (184.57, 253.54)110.25 (82.53, 143.86)−2.62 (−2.92, −2.33) Tropical Latin America4613 (4263, 4992)2111 (1919, 2319)139.07 (128.29, 150.69)61.02 (55.61, 66.96)−1.81 (−2.35, −1.27) Southern Latin America595 (515, 694)299 (235, 377)57.60 (49.71, 66.69)38.93 (30.79, 49.01)−0.74 (−0.95, −0.53) Central Europe494 (431, 561)52 (44, 62)29.30 (25.50, 33.29)5.08 (4.28, 5.98)−5.57 (−5.83, −5.32) Eastern Europe1355 (1160, 1548)201 (168, 245)45.92 (39.46, 51.89)11.23 (9.28, 13.62)−5.59 (−5.96, −5.22) Western Europe435 (392, 488)156 (138, 175)9.46 (8.54, 10.62)3.82 (3.37, 4.25)−2.48 (−2.74, −2.22) High-income Asia Pacific346 (302, 392)72 (61, 84)17.61 (15.32, 20.10)6.12 (5.20, 7.21)−3.40 (−3.61, −3.19) High-income North America559 (478, 652)1114 (961, 1318)12.33 (10.59, 14.41)27.75 (23.91, 32.93)3.80 (3.43, 4.17) Global and regional number of maternal deaths, maternal mortality ratio (MMR; number of deaths per 100 000 livebirths), and estimated annual percentage change of MMR, 1990–2021 The decline in MMR was not linear, with a faster rate of reduction in the early 2000 s and a more gradual or plateaued decline in recent years. In the context of the SDGs, the global MMR showed an average annual decline of −2.18 (95% UI −2.36, −2.00) (Table 1), demonstrating consistent progress over the past three decades. Maternal death risk across different age groups and associated underlying causes Maternal death risk varied significantly across different age groups, with the highest risks observed among younger women aged 10–19 and older women aged 35–49. MMR and age showed a U-shaped distribution (Fig. 1C). The lowest MMR is observed in the 20–24 and 25–29 age groups, which represent the peak reproductive years (Fig. 1C). MMR showed a gradual increase starting from the 30–34 age group. Compared to the 20–24 and 25–29 age groups, MMR was higher in the 10–14, 15–19, 35–39, 40–44, and 45–49 age groups, with the highest MMR observed in the 45–49 age group (Fig. 1C). However, the primary disease factors contributing to maternal deaths differ across age groups (Fig. 1D). Maternal hemorrhage and maternal hypertensive disorders were the leading causes of maternal death across all age groups, although their proportions varied, with the highest proportions observed in the 20–24 and 25–29 age groups. With increasing age, the proportion of maternal deaths attributable to other direct maternal disorders gradually increased from the 30–34 age group onwards. In the older age group of 45–49, the proportion of maternal deaths due to maternal hemorrhage and maternal hypertensive disorders slightly decreased, while deaths due to other direct maternal disorders and maternal abortion and miscarriage increased. Disparities in MMR by SDI We analyzed MMR across different SDI regions to explore the relationship between MMR and SDI. The results revealed significant trends in MMR across SDI categories over the three-decade study period (Fig. 1E). High SDI regions consistently exhibited the lowest MMR throughout the study period. In 1990, the MMR in High SDI regions was 17.14 per 100,000 live births, which slightly increased to 17.76 per 100,000 live births by 2021 (Table 1). This suggests potential stagnation or challenges in further reducing MMR in High SDI regions. High-middle SDI and Middle SDI countries showed a gradual decline in MMR during the study period (Fig. 1E and Table 1). Low-middle SDI regions demonstrated a notable decline in MMR during the study period (Fig. 1E and Table 1). Low SDI regions consistently exhibited the highest MMR throughout the study period (Fig. 1E and Table 1). Additionally, we plotted the fitted curves illustrating the correlation between MMR and SDI across global SDI regions and specific geographic locations (Fig. 2). There was a nonlinear negative correlation between the MMR and the SDI. Specifically, as the SDI increases from low (0.3–0.5) to medium levels (0.5–0.7), the MMR decreases sharply, while plateauing in High SDI regions (0.7–0.9). Notably, regions with the lowest SDI values, particularly Sub-Saharan Africa (e.g., Western, Central, and Eastern Sub-Saharan Africa), exhibited the highest MMR, whereas high-income regions (e.g., High-income North America, Western Europe, and Australia) consistently showed the lowest MMR. South Asia and Southeast Asia demonstrated moderate SDI levels but experienced a faster decline in MMR compared to regions with similar SDI, suggesting the influence of additional factors on maternal and child health outcomes. In contrast, Latin America and the Caribbean displayed lower-than-expected MMR values relative to their SDI, potentially reflecting targeted healthcare interventions. Fitted curves of MMR and SDI for global and GBD regions from 1990 to 2021. The colored dashed lines display the MMR for global and regional values. Each point on the dashed line represents a year, starting from 1990 and ending in 2021. In all regions, the SDI has increased over time, so progress in SDI is associated with points further to the right and later years for a given region. The black solid lines represent the expected trajectories for each region based on SDI alone. SDI = Sociodemographic Index Regional and national distribution of MMR Globally, the overall MMR has shown a declining trend, with most countries experiencing a reduction in MMR during the study period. The EAPC reflected the rate of change in MMR, and most countries exhibited negative EAPC values, indicating progress in reducing MMR. However, the rate of decline varied significantly across regions and countries. Countries in regions such as Northern Europe, Australasia, Central Europe, and Western Europe exhibit the lowest MMR (Fig. 3A). The Caribbean, Central America, and the Southeast Asia regions observed moderate-to-low MMR levels (Fig. 3A). In contrast, resource-limited regions were predominantly characterized by higher MMR levels, with West Africa and Central Africa reporting the highest MMR (Fig. 3A). MMR and EAPC across 204 countries and territories in 2021. A MMR across 204 countries and territories in 2021. This circular heatmap is color-coded based on the MMR across 204 countries and territories globally in 2021. The lowest MMR is shown in blue, and the highest in red. B In 2021, the observed EAPC in MMR for each country and region. This circular heatmap shows the observed annual percentage change in MMR in 2021. Positive EAPC values indicate an increasing trend in the indicator over the observation period, signifying a rising burden. Negative EAPC values suggest a decreasing trend, indicating a reduction in the burden. EAPC values close to zero reflect minimal changes in the burden, indicating stability Additionally, we analyzed the EAPC of MMR across global regions in 2021 and compared it with the expected trends based on SDI (Fig. 3B). The EAPC was categorized into three intervals: − 8 to − 4, − 4 to − 0, 0 to 4, reflecting the decline or rise in MMR relative to SDI predictions. Notably, regions with the most significant MMR reductions included Northern Europe, China and Balkans (Fig. 3B). West Africa and the Eastern Mediterranean regions observed moderate declines. In contrast, Caribbean and Central America exhibited stagnation or weak positive trends. The Persian Gulf region showed an accelerated increase in MMR. Within sub-Saharan Africa, Zimbabwe shows a worsening MMR trend over 1990–2021, in contrast to declines observed in most other sub-Saharan African countries (Fig. 3B). Regional disparity analyses reveal significant variations in MMR, with Central Sub-Saharan Africa exhibiting the highest global MMR, emphasizing the severe burden of maternal deaths in this region (Fig. 3B and Table 1). South Asia also bears a high burden of maternal deaths, but significant reductions in MMR during the study period indicate notable improvements (Fig. 3B and Table 1). Regions such as North America and Europe maintained relatively low MMR levels with minimal changes over the study period (Fig. 3B and Table 1). However, inequalities persist, particularly in low SDI regions and areas such as Sub-Saharan Africa and South Asia, where MMR remains unacceptably high. High SDI regions show stagnation or slight increases in MMR (Fig. 3B and Table 1). National trend analyses reveal complexities in countries such as Afghanistan (Table S1). Although Afghanistan’s MMR declined from 522.49 per 100,000 live births in 1990 to 304.82 in 2021, the number of maternal deaths increased from 2,347 in 1990 to 3,689 in 2021. The EAPC of MMR was −1.15%, indicating slower progress in reducing MMR compared to other countries. Albania demonstrated significant improvements, with substantial declines in both maternal deaths and MMR. Bangladesh has made significant progress, with both MMR and maternal deaths declining dramatically by about 70% over the study period. Other middle-income countries, such as Algeria, also showed varying degrees of improvement, with reductions in both MMR and maternal deaths. Regional variations in leading causes of maternal deaths We analyzed the top ten causes of maternal deaths across different regions, as illustrated in Fig. 4. The results revealed significant regional differences in the leading causes of maternal death. Globally, maternal hemorrhage dominated as the primary cause of maternal deaths. Across regions with different SDI levels, the ranking of maternal deaths causes shows distinct patterns. In low SDI regions, maternal hemorrhage and maternal hypertensive disorders dominate the rankings. In contrast, in high SDI regions, maternal abortion and miscarriage, as well as ectopic pregnancy, are the primary causes in 2021. In middle SDI regions, the leading causes of maternal deaths remained largely unchanged between 1990 and 2021, with maternal hemorrhage and maternal hypertensive disorders consistently ranking highest. Heatmap of ranked causes of maternal deaths based on SDI distribution and global GBD regional distribution for 1990 and 2021. This heatmap ranks the causes of maternal death, with the horizontal axis representing SDI regions and global GBD regional distribution, and the vertical axis representing the 10 most common disease factors leading to maternal death Across the sub-regions of Sub-Saharan Africa, maternal hemorrhage consistently remains one of the leading causes of maternal deaths. However, the ranking of other causes varies across subregions. In Eastern, Western, and Central Sub-Saharan Africa, maternal hemorrhage, maternal hypertensive disorders, and maternal abortion and miscarriage are the top three causes of maternal death. In Southern Sub-Saharan Africa, maternal abortion and miscarriage, other direct maternal disorders, and maternal hypertensive disorders rank as the top three causes. In North Africa and the Middle East, compared to 1990, when maternal hypertensive disorders and maternal hemorrhage were the top causes, the primary causes in 2021 were maternal hemorrhage and other direct maternal disorders, ranking first and second, respectively. Maternal abortion and miscarriage are also prominent, ranking within the top five. In South Asia, in 2021, Maternal hypertensive disorders and maternal hemorrhage were the leading causes of maternal deaths. Maternal sepsis and other infections, as well as other direct maternal disorders, are also important, ranking within the top five. Abortion and spontaneous abortion rank lower in this region compared to others. Southeast Asia is similar to South Asia, with maternal hemorrhage being the leading cause of maternal deaths, followed by maternal hypertensive disorders and maternal abortion and miscarriage. Maternal sepsis and other maternal infections, as well as other direct maternal disorders, are also significant causes, ranking within the top five. Maternal deaths related to HIV/AIDS are less prominent in this region, ranking lower. In the Caribbean, maternal hypertensive disorders are the leading cause of maternal deaths, followed by maternal hemorrhage and indirect maternal deaths. Maternal sepsis and other infections, as well as maternal abortion and miscarriage, are also important, ranking within the top five. Maternal deaths related to HIV/AIDS rank lower in this region. In summary, the heatmap highlights the regional and socioeconomic variations in the causes of maternal deaths. Maternal hemorrhage, maternal hypertensive disorders, and maternal sepsis and other infections consistently rank as leading causes across most regions, although their specific rankings vary. Discussion The global decline in MMR from 260.02 to 147.77 per 100,000 live births between 1990- and 2021-marks significant progress in maternal healthcare, yet persistent disparities across regions, age groups, and countries with differing national-level SDI rankings underscore the urgent need for context-specific, equity-driven strategies. This trend reflects the cumulative impact of global health initiatives, improvements in maternal healthcare services, and targeted interventions aimed at reducing MMR. While advancements in skilled birth attendance [21], emergency obstetric care [22], and policy prioritization may have driven reductions, evidence from the WHO Multicountry Survey indicates that high coverage of essential interventions alone does not necessarily translate into reduced maternal mortality [23]. Substantial progress requires moving beyond essential interventions to ensure comprehensive emergency care and overall improvements in the quality of maternal health services. The observed decline in maternal deaths (342,498 to 191,152) aligns with global investments in maternal health infrastructure, including expanded access to oxytocin [24] for postpartum hemorrhage (PPH) [25] and antenatal care [26]. However, the nonlinear trajectory of MMR reduction—steeper declines in the early 2000 s followed by stagnation—signals systemic challenges. High SDI regions demonstrate this phenomenon: the MMR has increased slightly compared to previous levels, which may reflect insufficient attention to emerging risks, including advanced maternal age [27], obesity-related complications [28–30], and inequities in healthcare access for marginalized populations [31]. The slower decline in the number of maternal deaths compared to MMR can be explained in part by population growth and an increase in live births in certain regions, particularly in LMICs. Conversely, countries with low national-level SDI—particularly in sub-Saharan Africa—still contribute a disproportionate share of global maternal deaths, despite recent declines in MMR, reflecting population growth and persistent health-system constraints. The slow progress in these countries can also be attributed to challenges such as limited healthcare resources, insufficient maternal health services, and socioeconomic barriers. The persistently high MMR underscores the need for further investment in maternal healthcare infrastructure and services. Beyond country-specific examples, the global decline in maternal mortality reflects the cumulative influence of broader structural and systemic determinants. Improvements in female education, fertility reduction, and the expansion of universal health coverage have collectively contributed to enhanced maternal health outcomes. Strengthened health information systems, together with the scale-up of skilled birth attendance, family planning, and emergency obstetric services, have further accelerated reductions in MMR. However, the recent stagnation or reversal observed in certain regions indicates that progress is increasingly constrained by deeper systemic challenges, including health workforce shortages, inequitable resource distribution, fragile health systems in conflict-affected settings, and the growing burden of noncommunicable diseases. Furthermore, global crises—such as the COVID-19 pandemic, climate-related disruptions, and widening economic inequality—have exacerbated these constraints, straining already limited maternal health programs. These intersecting challenges underscore that sustaining progress requires not only expanding access to essential services but also reinforcing health system resilience and embedding equity as a central pillar of global maternal health strategies. The U-shaped MMR curve—peaking in adolescents (10–19 years) and older women (35–49)—reveals intersecting biological and sociostructural risks. Adolescents face heightened mortality from maternal hypertensive disorders and maternal hemorrhage, compounded by physiological immaturity [32], limited reproductive autonomy [33], and stigma-driven barriers to care. In sub-Saharan Africa, adolescents experience the highest maternal mortality rates, reflecting a disproportionate risk driven by early marriage and limited access to contraception [34]. For older women, risks shift toward multifetal pregnancies [35] (linked to assisted reproductive technologies [36, 37]) and chronic conditions (e.g., diabetes, hypertension [38]). Japan’s rising maternal deaths among women ≥ 40, paralleling delayed childbearing trends, underscore the need for preconception care and comorbidity management [39]. These findings align with the WHO’s life-course approach, advocating for age-tailored interventions: youth-friendly sexual health services for adolescents and integrated chronic disease management for older mothers. While the inverse correlation between SDI and MMR underscores socioeconomic development’s role, outliers challenge deterministic narratives. Bangladesh, despite moderate SDI, reduced MMR by 70% through community health worker (CHW) programs [40] and emergency obstetric hubs [41] —a model replicated in Rwanda [42] and Nepal [43]. These countries exemplify how ‘positive-outlier’ nations can achieve rapid mortality declines through a combination of expanded service access, improved quality of care, strengthened health systems, fertility decline, and supportive socioeconomic development. Their experiences show that progress was not merely about adopting global recommendations but about progressively scaling up implementation in line with national contexts and transitions. This aligns with Campbell’s recent work, which emphasizes learning from success in exemplar countries and highlights that strategies must evolve over time and cannot follow a one-size-fits-all approach [44]. Conversely, high SDI regions like the U.S. and Persian Gulf countries face stagnation or rising MMR, driven by fragmented care, structural racism, and reliance on transient healthcare workers. For instance, Black women in the U.S. experience MMR 2–4 times higher than white women [45], reflecting systemic underinvestment in safety-net hospitals—institutions that provide care regardless of patients’ insurance status or ability to pay, and disproportionately serve uninsured, publicly insured, and socially marginalized populations. These facilities are often teaching hospitals in metropolitan areas, offering broad service lines including emergency and mental health care, yet face chronic financial strain. Similarly, Saudi Arabia’s rising MMR highlights gaps in continuity of care despite high resource availability. In contrast, Zimbabwe, a low-SDI country in Southern Sub-Saharan Africa, exhibits a concerning increase in MMR, diverging from the moderate declines observed in most other sub-Saharan African countries (Fig. 3B). This deterioration may be driven by persistent economic instability, healthcare workforce shortages, and limited access to emergency obstetric care [46, 47], highlighting the need for targeted interventions to address these systemic challenges. These paradoxes emphasize that SDI is a starting point, not an endpoint; equitable policy implementation—such as implicit bias training for providers and Medicaid expansion for postpartum care [48] —is critical to translate resources into outcomes. Leading causes of maternal deaths diverge starkly by region, reflecting disparities in health system capacity. These regional variations align with the concepts of the “maternal mortality transition” and “obstetric transition,” which describe the gradual shift from high maternal mortality dominated by direct obstetric causes toward lower levels characterized by indirect and noncommunicable causes, alongside changes in fertility, health-system capacity, and patterns of obstetric intervention [49, 50]. According to this framework, countries and regions move through five stages, from very high maternal mortality and limited access to care (Stage I–II), through phases where quality of care becomes decisive (Stage III), to contexts with relatively low maternal mortality where indirect causes and over-medicalization predominate (Stage IV–V) [50]. This lens helps to explain why in sub-Saharan Africa, maternal hemorrhage and hypertensive disorders remain leading causes, whereas in higher-SDI regions, indirect causes and noncommunicable conditions play a growing role. In sub-Saharan Africa, maternal hemorrhage and maternal hypertensive disorders of pregnancy predominate, and these problems may be exacerbated by oxytocin shortages and delays in accessing medical care. Nigeria’s success in reducing PPH deaths—through misoprostol distribution and blood bank networks—demonstrates scalable solutions [51]. In contrast, high SDI regions grapple with abortion-related complications and indirect causes (e.g., mental health crises, cardiovascular disease) [52]. France’s near-miss surveillance system, tracking severe maternal morbidity, offers a model for addressing iatrogenic risks [53]. Latin America’s lower-than-expected MMR, despite moderate SDI, reflects innovations like Brazil’s Rede Cegonha program, which combines conditional cash transfers with midwife-led care [54]. These examples underscore the need for region-specific strategies: scaling emergency transport systems in LMICs and enhancing early pregnancy surveillance in high-income settings. In Afghanistan, despite a 42% MMR decline since 1990, absolute maternal deaths rose by 57% due to population growth and conflict-driven healthcare collapse [55]. Climate change further exacerbates risks: droughts in the Sahel disrupt antenatal access [56], while South Asia’s floods increase maternal malnutrition and waterborne diseases [57, 58]. Colonial legacies persist in Francophone Africa, where underfunded health systems—shaped by extractive policies—struggle to retain skilled staff [59, 60]. Addressing these inequities demands reparative approaches: redirecting aid from vertical programs to health system strengthening and embedding maternal health within climate adaptation frameworks. In this regard, enhanced obstetric surveillance systems and detailed multidisciplinary clinical audit of maternal deaths have proven to be highly effective in identifying risk factors, improving data completeness, and guiding targeted interventions to reduce MMR. The European Board and College of Obstetrics and Gynaecology has recently emphasized the need for robust maternal mortality surveillance systems across Europe, calling for structured case ascertainment, external audits, and ‘no blame, no shame’ learning frameworks as essential components of health system strengthening [61]. The global MMR exhibited a decline from 1990 to 2021. This trajectory reflects the cumulative impact of targeted global health initiatives, improvements in maternal healthcare infrastructure, and evidence-based interventions such as skilled birth attendance and emergency obstetric care. Age-specific analyses revealed dynamic shifts in mortality etiology: PPH and hypertensive disorders remained leading causes across all groups, while indirect maternal causes varied significantly by age, necessitating tailored interventions for adolescents and older mothers. Geographically, stark disparities persisted, with Sub-Saharan Africa and conflict-affected regions bearing the highest MMR burdens, contrasted against high-income regions where stagnation or slight increases in MMR signal emerging risks linked to advanced maternal age and chronic comorbidities. SDI strongly predicted MMR reduction globally, yet outliers such as Tropical Latin America and the Caribbean demonstrated the critical role of regional policies and healthcare investments in defying SDI-based expectations. These findings collectively emphasize that while global progress is evident, achieving equity in maternal survival demands sustained innovation, resource allocation to LMICs, and adaptive policies addressing both persistent and emerging determinants of risk. To overcome stagnation, LMICs must integrate maternal health with broader development agendas. Ethiopia's Health Extension Program reduced MMR by 50% in 10 years by training community workers to provide antenatal care [62, 63]. In addition, the advancement of artificial intelligence has enabled digital innovations to enhance care accessibility and improve data accuracy. Globally, cross-sector collaboration is essential: linking maternal health to girls’ education (reducing adolescent pregnancies) and economic empowerment (e.g., microfinance for women). These strategies recognize that maternal survival hinges not only on medical interventions but on dismantling structural barriers. While this study leverages GBD data, underreporting in conflict zones and ecological fallacies in SDI-based analyses limit granularity. A particularly important limitation is the underestimation of maternal deaths due to incomplete or inaccurate death registration, which has been shown to substantially bias MMR estimates even in high-income settings when only vital registration data are used. Evidence from enhanced surveillance systems in Europe demonstrates that routine registration alone underreports maternal deaths, leading to significant underestimation of the true burden [53]. Additionally, the GBD modelling approach relies on multiple data sources of varying quality, which may introduce inconsistencies and biases, especially in countries with limited vital registration systems [16]. The use of statistical modelling to estimate maternal mortality in data-sparse regions can result in wide UI and may not fully capture local epidemiological patterns [17]. Furthermore, the reliance on aggregated national-level indicators may obscure important subnational disparities and context-specific risk factors. It is noteworthy that a key methodological consideration in maternal mortality research is the definition of "maternal death," which varies notably between major data sources. Within the framework of the GBD and the WHO ICD-11, a key difference exists in the delineation of the time frame. According to the WHO's ICD-11 standard, a maternal death is defined as "the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes. This definition primarily encompasses direct obstetric causes (e.g., postpartum hemorrhage, eclampsia) and indirect obstetric causes (where pregnancy aggravates an existing disease), while deaths related to these causes occurring between 42 days and one year after termination of pregnancy are classified separately as 'late maternal deaths'. In contrast, the GBD study adopts a broader time frame. Its 2021 study defined maternal deaths as all deaths due to obstetric complications (direct maternal deaths) or pre-existing diseases exacerbated by pregnancy (indirect maternal deaths), with such deaths occurring within one year of the end of pregnancy being counted, regardless of how the pregnancy was terminated, while excluding accidental or incidental causes. This means the GBD extends its definition to include the first postpartum year, thereby incorporating into its overall estimates of maternal death burden the 'late maternal deaths' that are classified separately under ICD-11. This definitional discrepancy may lead to higher estimates of the global number and ratio of maternal deaths from the GBD compared to estimates strictly adhering to the ICD-11 standard (which only counts deaths within 42 days), as it includes more of the longer-term impacts related to pregnancy. These limitations highlight the need for improved data collection, validation, and integration of qualitative insights to enhance the accuracy and relevance of future maternal health research. Future research should employ mixed methods to explore qualitative barriers (e.g., gender norms, distrust in health systems) and evaluate emerging solutions like AI-driven risk prediction or drone-delivered blood products. Longitudinal studies assessing post-pandemic MMR trajectories are critical, as COVID-19 disrupted decades of progress in regions like South Asia [13]. Centering maternal voices—through participatory research with survivors—can humanize data and inform person-centered policies. Overall, the global reduction in MMR reflects advancements in healthcare, yet the enduring burden in marginalized communities demands radical action. Achieving SDGs targets requires dismantling structural inequities—colonial health system legacies, gender-based violence, and climate injustice—and reimagining maternal health as a cornerstone of social justice. Policymakers must prioritize intersectional approaches: investing in midwifery workforces, decolonizing global health financing, and embedding maternal health within climate resilience frameworks. As the 2030 deadline looms, the world faces a moral choice: Will maternal survival remain a lottery of birth, or become a universal right? The outcome depends on our ability to implement practical solutions, ensure fair access to healthcare, and address systemic inequalities. Conclusions Although global MMR has generally declined, significant disparities persist in certain regions and demographic groups. Achieving the SDGs requires targeted interventions to address medical disparities and age-related risks. This includes strengthening health data systems, expanding maternal and child health services coverage, and improving access to high-quality contraception and safe abortion services. Furthermore, enhancing health system monitoring, ensuring the accessibility of routine reproductive healthcare and emergency obstetric services, and reducing maternal deaths through proactive surveillance and intervention remain imperative. Evaluating the SDI is essential for developing tailored strategies to optimize health system performance, ultimately advancing progress toward the SDGs and improving maternal health outcomes worldwide. Supplementary Information Supplementary Material 1 Supplementary Material 2. Table S1: 204 national or territory number of maternal deaths, maternal mortality ratio (MMR; number of deaths per 100 000 livebirths), and estimated annual percentage change of MMR, 1990–2021 Acknowledgements We extend our gratitude to the Global Burden of Disease Study 2021 collaborators for their invaluable contributions. We also acknowledge the efforts of all individuals involved in GBD 2021 for their dedication to data collection, organization, analysis, and communication facilitation. Abbreviations Community Health Worker Cause-of-Death Ensemble modeling Estimated Annual Percentage Change Global Burden of Disease International Classification of Diseases, 10th Revision Low- and Middle-income Countries Maternal Mortality Ratio Postpartum Hemorrhage Sustainable Development Goals Socio-demographic Index Uncertainty Intervals World Health Organization Authors’ contributions Y.Z. and C. C. were responsible for conceptualization, funding acquisition, and project supervision. Y.W., H.L., and X.Y.L. were involved in data organization and analysis, software implementation, visualization, and manuscript writing. All authors were involved in reviewing and editing the manuscript. Funding National Key R&D Program of China (grant number 2022YFC2704103 to Y. Z.), National Natural Science Foundation of China (82203453 to C.C.), Natural Science Foundation of Hubei (JCZRYB202500332 to C.C.). Data availability Data from this article are available in the Global Burden of Disease Study 2021 at [https://vizhub.healthdata.org/gbd-results/](https://vizhub.healthdata.org/gbd-results). Declarations Ethics approval and consent to participate Ethical approval and informed consent were waived because the GBD data are publicly available and contain no identifiable information. According to the policy of the Institute for Health Metrics and Evaluation and relevant national regulations, ethics approval was deemed unnecessary. All analyses were conducted in accordance with the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Ye Wei, Hong Luo and Xiaoyu Liu co-first author. Contributor Information Canhui Cao, Email: canhuicao@tjh.tjmu.edu.cn. Ying Zheng, Email: zhengying@scu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2. Table S1: 204 national or territory number of maternal deaths, maternal mortality ratio (MMR; number of deaths per 100 000 livebirths), and estimated annual percentage change of MMR, 1990–2021 Data Availability Statement Data from this article are available in the Global Burden of Disease Study 2021 at [https://vizhub.healthdata.org/gbd-results/](https://vizhub.healthdata.org/gbd-results).